Benchmark share indices ended lower on Monday recording their highest single day fall since August 8 after sluggish July domestic industrial growth and weaker-than-expected economic data from China......
Germany-based Merck KGaA, the world's oldest multinational pharmaceutical company, is eyeing to acquire a prominent Indian pharmaceutical company and established drug brands. This is part of......
Glenmark Pharmaceuticals has received a milestone payment of $15 million from US-based Forest Laboratories as part of the drug development agreement for its lead molecule Oglemilast (GRC 3886),......
Glenmark Pharmaceuticals, India's 11th biggest drug maker by sales, may beat bigger rivals, including Ranbaxy, Dr Reddy's and Nicholas Piramal, in selling an original drug, or novel chemical......
Close on the heels of global pharmaceutical giants, international bio-technology companies also find India an irresistible attraction, though for different reasons. If the low-cost availability of......